General Anesthesia Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Type (Sevoflurane, Desflurane, Propofol, Dexmedetomidine, Remifentanil, Midazolam, Others); Route of Administration (Injection, Inhalation); End User (Hospitals, Ambulatory Surgical Centers, Others); and Geography
Report Code: TIPRE00006928 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
General anesthesia drugs provide a patient a reversibly unconscious and unresponsive stage which allow surgeons to operate on that patient. General anesthetics drugs are generlly administered intravenously or by inhalation by anesthetist. An anesthetist also monitors the patient's vital signs during the procedure. As the patient is unconscious he or she is not able to feel pain however, in some cases it may result a short term memory loss when patient is conscious).
MARKET DYNAMICS
The general anesthesia drugs market is expected to grow owing to the key factors such as rising incidences of chronic diseases, rising numbers surgeries, rising generic pharmaceutical manufacturing and more. The development in the pharmaceutical industry across the world is likely to widen up growth opportunities for the market during the forecast period.
MARKET SCOPE
The "Global General Anesthesia Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of general anesthesia drugs market with detailed market segmentation by type, route of administration, end user and geography. The global general anesthesia drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading general anesthesia drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global general anesthesia drugs market is segmented on the basis of type, route of administration and end user. Based on the type the market is segmented as sevoflurane, desflurane, propofol, dexmedetomidine, remifentanil, midazolam, and others. Based on the rout of administration the market is classified as injection, and inhalation On the basis of end user the market is categorized as hospitals, ambulatory surgical centers, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global general anesthesia drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The general anesthesia drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting general anesthesia drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the general anesthesia drugs market in these regions.
The reports cover key developments in the general anesthesia drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from general anesthesia drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for general anesthesia drugs market in the global market. Below mentioned is the list of few companies engaged in the general anesthesia drugs market.
The report also includes the profiles of key general anesthesia drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
General anesthesia drugs provide a patient a reversibly unconscious and unresponsive stage which allow surgeons to operate on that patient. General anesthetics drugs are generlly administered intravenously or by inhalation by anesthetist. An anesthetist also monitors the patient's vital signs during the procedure. As the patient is unconscious he or she is not able to feel pain however, in some cases it may result a short term memory loss when patient is conscious).
MARKET DYNAMICS
The general anesthesia drugs market is expected to grow owing to the key factors such as rising incidences of chronic diseases, rising numbers surgeries, rising generic pharmaceutical manufacturing and more. The development in the pharmaceutical industry across the world is likely to widen up growth opportunities for the market during the forecast period.
MARKET SCOPE
The "Global General Anesthesia Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of general anesthesia drugs market with detailed market segmentation by type, route of administration, end user and geography. The global general anesthesia drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading general anesthesia drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global general anesthesia drugs market is segmented on the basis of type, route of administration and end user. Based on the type the market is segmented as sevoflurane, desflurane, propofol, dexmedetomidine, remifentanil, midazolam, and others. Based on the rout of administration the market is classified as injection, and inhalation On the basis of end user the market is categorized as hospitals, ambulatory surgical centers, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global general anesthesia drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The general anesthesia drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting general anesthesia drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the general anesthesia drugs market in these regions.
The reports cover key developments in the general anesthesia drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from general anesthesia drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for general anesthesia drugs market in the global market. Below mentioned is the list of few companies engaged in the general anesthesia drugs market.
The report also includes the profiles of key general anesthesia drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Par Pharmaceutical, Inc.
- Fresenius Kabi USA, LLC
- Pfizer Inc.
- Baxter International Inc.
- AbbVie Inc.
- Aspen Holdings
- Richter Pharma AG
- B. Braun Melsungen AG
- Mylan N.V
- Eisai Co., Ltd.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 General Anesthesia Drugs Market - By Type
1.3.2 General Anesthesia Drugs Market - By Route of Administration
1.3.3 General Anesthesia Drugs Market - By End User
1.3.4 General Anesthesia Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENERAL ANESTHESIA DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENERAL ANESTHESIA DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GENERAL ANESTHESIA DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GENERAL ANESTHESIA DRUGS - GLOBAL MARKET OVERVIEW
6.2. GENERAL ANESTHESIA DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENERAL ANESTHESIA DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SEVOFLURANE
7.3.1. Overview
7.3.2. Sevoflurane Market Forecast and Analysis
7.4. DESFLURANE
7.4.1. Overview
7.4.2. Desflurane Market Forecast and Analysis
7.5. PROPOFOL
7.5.1. Overview
7.5.2. Propofol Market Forecast and Analysis
7.6. DEXMEDETOMIDINE
7.6.1. Overview
7.6.2. Dexmedetomidine Market Forecast and Analysis
7.7. REMIFENTANIL
7.7.1. Overview
7.7.2. Remifentanil Market Forecast and Analysis
7.8. MIDAZOLAM
7.8.1. Overview
7.8.2. Midazolam Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. GENERAL ANESTHESIA DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTION
8.3.1. Overview
8.3.2. Injection Market Forecast and Analysis
8.4. INHALATION
8.4.1. Overview
8.4.2. Inhalation Market Forecast and Analysis
9. GENERAL ANESTHESIA DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. GENERAL ANESTHESIA DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America General Anesthesia Drugs Market Overview
10.1.2 North America General Anesthesia Drugs Market Forecasts and Analysis
10.1.3 North America General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.1.4 North America General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.1.6 North America General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States General Anesthesia Drugs Market
10.1.6.1.1 United States General Anesthesia Drugs Market by Type
10.1.6.1.2 United States General Anesthesia Drugs Market by Route of Administration
10.1.6.1.3 United States General Anesthesia Drugs Market by End User
10.1.6.2 Canada General Anesthesia Drugs Market
10.1.6.2.1 Canada General Anesthesia Drugs Market by Type
10.1.6.2.2 Canada General Anesthesia Drugs Market by Route of Administration
10.1.6.2.3 Canada General Anesthesia Drugs Market by End User
10.1.6.3 Mexico General Anesthesia Drugs Market
10.1.6.3.1 Mexico General Anesthesia Drugs Market by Type
10.1.6.3.2 Mexico General Anesthesia Drugs Market by Route of Administration
10.1.6.3.3 Mexico General Anesthesia Drugs Market by End User
10.2. EUROPE
10.2.1 Europe General Anesthesia Drugs Market Overview
10.2.2 Europe General Anesthesia Drugs Market Forecasts and Analysis
10.2.3 Europe General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany General Anesthesia Drugs Market
10.2.6.1.1 Germany General Anesthesia Drugs Market by Type
10.2.6.1.2 Germany General Anesthesia Drugs Market by Route of Administration
10.2.6.1.3 Germany General Anesthesia Drugs Market by End User
10.2.6.2 France General Anesthesia Drugs Market
10.2.6.2.1 France General Anesthesia Drugs Market by Type
10.2.6.2.2 France General Anesthesia Drugs Market by Route of Administration
10.2.6.2.3 France General Anesthesia Drugs Market by End User
10.2.6.3 Italy General Anesthesia Drugs Market
10.2.6.3.1 Italy General Anesthesia Drugs Market by Type
10.2.6.3.2 Italy General Anesthesia Drugs Market by Route of Administration
10.2.6.3.3 Italy General Anesthesia Drugs Market by End User
10.2.6.4 Spain General Anesthesia Drugs Market
10.2.6.4.1 Spain General Anesthesia Drugs Market by Type
10.2.6.4.2 Spain General Anesthesia Drugs Market by Route of Administration
10.2.6.4.3 Spain General Anesthesia Drugs Market by End User
10.2.6.5 United Kingdom General Anesthesia Drugs Market
10.2.6.5.1 United Kingdom General Anesthesia Drugs Market by Type
10.2.6.5.2 United Kingdom General Anesthesia Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom General Anesthesia Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific General Anesthesia Drugs Market Overview
10.3.2 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia General Anesthesia Drugs Market
10.3.6.1.1 Australia General Anesthesia Drugs Market by Type
10.3.6.1.2 Australia General Anesthesia Drugs Market by Route of Administration
10.3.6.1.3 Australia General Anesthesia Drugs Market by End User
10.3.6.2 China General Anesthesia Drugs Market
10.3.6.2.1 China General Anesthesia Drugs Market by Type
10.3.6.2.2 China General Anesthesia Drugs Market by Route of Administration
10.3.6.2.3 China General Anesthesia Drugs Market by End User
10.3.6.3 India General Anesthesia Drugs Market
10.3.6.3.1 India General Anesthesia Drugs Market by Type
10.3.6.3.2 India General Anesthesia Drugs Market by Route of Administration
10.3.6.3.3 India General Anesthesia Drugs Market by End User
10.3.6.4 Japan General Anesthesia Drugs Market
10.3.6.4.1 Japan General Anesthesia Drugs Market by Type
10.3.6.4.2 Japan General Anesthesia Drugs Market by Route of Administration
10.3.6.4.3 Japan General Anesthesia Drugs Market by End User
10.3.6.5 South Korea General Anesthesia Drugs Market
10.3.6.5.1 South Korea General Anesthesia Drugs Market by Type
10.3.6.5.2 South Korea General Anesthesia Drugs Market by Route of Administration
10.3.6.5.3 South Korea General Anesthesia Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa General Anesthesia Drugs Market Overview
10.4.2 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa General Anesthesia Drugs Market
10.4.6.1.1 South Africa General Anesthesia Drugs Market by Type
10.4.6.1.2 South Africa General Anesthesia Drugs Market by Route of Administration
10.4.6.1.3 South Africa General Anesthesia Drugs Market by End User
10.4.6.2 Saudi Arabia General Anesthesia Drugs Market
10.4.6.2.1 Saudi Arabia General Anesthesia Drugs Market by Type
10.4.6.2.2 Saudi Arabia General Anesthesia Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia General Anesthesia Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America General Anesthesia Drugs Market Overview
10.5.2 South and Central America General Anesthesia Drugs Market Forecasts and Analysis
10.5.3 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil General Anesthesia Drugs Market
10.5.6.1.1 Brazil General Anesthesia Drugs Market by Type
10.5.6.1.2 Brazil General Anesthesia Drugs Market by Route of Administration
10.5.6.1.3 Brazil General Anesthesia Drugs Market by End User
10.5.6.2 Argentina General Anesthesia Drugs Market
10.5.6.2.1 Argentina General Anesthesia Drugs Market by Type
10.5.6.2.2 Argentina General Anesthesia Drugs Market by Route of Administration
10.5.6.2.3 Argentina General Anesthesia Drugs Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENERAL ANESTHESIA DRUGS MARKET, KEY COMPANY PROFILES
12.1. PAR PHARMACEUTICAL, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FRESENIUS KABI USA, LLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAXTER INTERNATIONAL INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBVIE INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASPEN HOLDINGS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. RICHTER PHARMA AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. B. BRAUN MELSUNGEN AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MYLAN N.V
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. EISAI CO., LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 General Anesthesia Drugs Market - By Type
1.3.2 General Anesthesia Drugs Market - By Route of Administration
1.3.3 General Anesthesia Drugs Market - By End User
1.3.4 General Anesthesia Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. GENERAL ANESTHESIA DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GENERAL ANESTHESIA DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. GENERAL ANESTHESIA DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. GENERAL ANESTHESIA DRUGS - GLOBAL MARKET OVERVIEW
6.2. GENERAL ANESTHESIA DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GENERAL ANESTHESIA DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SEVOFLURANE
7.3.1. Overview
7.3.2. Sevoflurane Market Forecast and Analysis
7.4. DESFLURANE
7.4.1. Overview
7.4.2. Desflurane Market Forecast and Analysis
7.5. PROPOFOL
7.5.1. Overview
7.5.2. Propofol Market Forecast and Analysis
7.6. DEXMEDETOMIDINE
7.6.1. Overview
7.6.2. Dexmedetomidine Market Forecast and Analysis
7.7. REMIFENTANIL
7.7.1. Overview
7.7.2. Remifentanil Market Forecast and Analysis
7.8. MIDAZOLAM
7.8.1. Overview
7.8.2. Midazolam Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. GENERAL ANESTHESIA DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTION
8.3.1. Overview
8.3.2. Injection Market Forecast and Analysis
8.4. INHALATION
8.4.1. Overview
8.4.2. Inhalation Market Forecast and Analysis
9. GENERAL ANESTHESIA DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. GENERAL ANESTHESIA DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America General Anesthesia Drugs Market Overview
10.1.2 North America General Anesthesia Drugs Market Forecasts and Analysis
10.1.3 North America General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.1.4 North America General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.1.6 North America General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States General Anesthesia Drugs Market
10.1.6.1.1 United States General Anesthesia Drugs Market by Type
10.1.6.1.2 United States General Anesthesia Drugs Market by Route of Administration
10.1.6.1.3 United States General Anesthesia Drugs Market by End User
10.1.6.2 Canada General Anesthesia Drugs Market
10.1.6.2.1 Canada General Anesthesia Drugs Market by Type
10.1.6.2.2 Canada General Anesthesia Drugs Market by Route of Administration
10.1.6.2.3 Canada General Anesthesia Drugs Market by End User
10.1.6.3 Mexico General Anesthesia Drugs Market
10.1.6.3.1 Mexico General Anesthesia Drugs Market by Type
10.1.6.3.2 Mexico General Anesthesia Drugs Market by Route of Administration
10.1.6.3.3 Mexico General Anesthesia Drugs Market by End User
10.2. EUROPE
10.2.1 Europe General Anesthesia Drugs Market Overview
10.2.2 Europe General Anesthesia Drugs Market Forecasts and Analysis
10.2.3 Europe General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.2.4 Europe General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany General Anesthesia Drugs Market
10.2.6.1.1 Germany General Anesthesia Drugs Market by Type
10.2.6.1.2 Germany General Anesthesia Drugs Market by Route of Administration
10.2.6.1.3 Germany General Anesthesia Drugs Market by End User
10.2.6.2 France General Anesthesia Drugs Market
10.2.6.2.1 France General Anesthesia Drugs Market by Type
10.2.6.2.2 France General Anesthesia Drugs Market by Route of Administration
10.2.6.2.3 France General Anesthesia Drugs Market by End User
10.2.6.3 Italy General Anesthesia Drugs Market
10.2.6.3.1 Italy General Anesthesia Drugs Market by Type
10.2.6.3.2 Italy General Anesthesia Drugs Market by Route of Administration
10.2.6.3.3 Italy General Anesthesia Drugs Market by End User
10.2.6.4 Spain General Anesthesia Drugs Market
10.2.6.4.1 Spain General Anesthesia Drugs Market by Type
10.2.6.4.2 Spain General Anesthesia Drugs Market by Route of Administration
10.2.6.4.3 Spain General Anesthesia Drugs Market by End User
10.2.6.5 United Kingdom General Anesthesia Drugs Market
10.2.6.5.1 United Kingdom General Anesthesia Drugs Market by Type
10.2.6.5.2 United Kingdom General Anesthesia Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom General Anesthesia Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific General Anesthesia Drugs Market Overview
10.3.2 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia General Anesthesia Drugs Market
10.3.6.1.1 Australia General Anesthesia Drugs Market by Type
10.3.6.1.2 Australia General Anesthesia Drugs Market by Route of Administration
10.3.6.1.3 Australia General Anesthesia Drugs Market by End User
10.3.6.2 China General Anesthesia Drugs Market
10.3.6.2.1 China General Anesthesia Drugs Market by Type
10.3.6.2.2 China General Anesthesia Drugs Market by Route of Administration
10.3.6.2.3 China General Anesthesia Drugs Market by End User
10.3.6.3 India General Anesthesia Drugs Market
10.3.6.3.1 India General Anesthesia Drugs Market by Type
10.3.6.3.2 India General Anesthesia Drugs Market by Route of Administration
10.3.6.3.3 India General Anesthesia Drugs Market by End User
10.3.6.4 Japan General Anesthesia Drugs Market
10.3.6.4.1 Japan General Anesthesia Drugs Market by Type
10.3.6.4.2 Japan General Anesthesia Drugs Market by Route of Administration
10.3.6.4.3 Japan General Anesthesia Drugs Market by End User
10.3.6.5 South Korea General Anesthesia Drugs Market
10.3.6.5.1 South Korea General Anesthesia Drugs Market by Type
10.3.6.5.2 South Korea General Anesthesia Drugs Market by Route of Administration
10.3.6.5.3 South Korea General Anesthesia Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa General Anesthesia Drugs Market Overview
10.4.2 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa General Anesthesia Drugs Market
10.4.6.1.1 South Africa General Anesthesia Drugs Market by Type
10.4.6.1.2 South Africa General Anesthesia Drugs Market by Route of Administration
10.4.6.1.3 South Africa General Anesthesia Drugs Market by End User
10.4.6.2 Saudi Arabia General Anesthesia Drugs Market
10.4.6.2.1 Saudi Arabia General Anesthesia Drugs Market by Type
10.4.6.2.2 Saudi Arabia General Anesthesia Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia General Anesthesia Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America General Anesthesia Drugs Market Overview
10.5.2 South and Central America General Anesthesia Drugs Market Forecasts and Analysis
10.5.3 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By Type
10.5.4 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America General Anesthesia Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil General Anesthesia Drugs Market
10.5.6.1.1 Brazil General Anesthesia Drugs Market by Type
10.5.6.1.2 Brazil General Anesthesia Drugs Market by Route of Administration
10.5.6.1.3 Brazil General Anesthesia Drugs Market by End User
10.5.6.2 Argentina General Anesthesia Drugs Market
10.5.6.2.1 Argentina General Anesthesia Drugs Market by Type
10.5.6.2.2 Argentina General Anesthesia Drugs Market by Route of Administration
10.5.6.2.3 Argentina General Anesthesia Drugs Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. GENERAL ANESTHESIA DRUGS MARKET, KEY COMPANY PROFILES
12.1. PAR PHARMACEUTICAL, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FRESENIUS KABI USA, LLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BAXTER INTERNATIONAL INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBVIE INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASPEN HOLDINGS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. RICHTER PHARMA AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. B. BRAUN MELSUNGEN AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MYLAN N.V
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. EISAI CO., LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Par Pharmaceutical, Inc.
2. Fresenius Kabi USA, LLC
3. Pfizer Inc.
4. Baxter International Inc.
5. AbbVie Inc.
6. Aspen Holdings
7. Richter Pharma AG
8. B. Braun Melsungen AG
9. Mylan N.V
10. Eisai Co., Ltd.